GMRE

Seasoned executive who founded and built an NYSE-listed healthcare real estate company to over $1 billion in enterprise value — delivering an average dividend yield of approximately 8.5% to shareholders — brings capital markets depth, healthcare sector expertise, and commercial discipline to lead Aditxt's next chapter of revenue-driven growth. Aditxt, Inc. (NASDAQ:ADTX)("Aditxt" or the "Company"), a life sciences platform company accelerating promising health innovations, today announced the appointment of Jeffrey M. Busch as Interim Chief Executive Officer of Aditxt, Inc., effective May 31, 2026. Mr. Busch, who has served as Chief Executive Officer of Aditxt's CLIA-certified precision on

Busch brings public company leadership and capital markets experience to support Ignite's next phase of growth Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most

8-K - Chiron Real Estate Inc. (0001533615) (Filer)

Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley. Please note, at the time it releases its fourth quarter and year-end 2025 financial results, the Company's previously

Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to "Chiron Real Estate Inc." Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the "NYSE") under the new name, "Chiron Real Estate Inc.," and ticker symbol "XRN." "After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission," Mark Decker, Jr., Chief Executive Officer, said. "Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered a

Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to reflect the Company's one-for-five reverse stock split that was effective on September 19, 2025. Stockholders should review their Forms 1099 as well as other 2025 tax statements that they will receive from their brokerage firms or o

8-K - Global Medical REIT Inc. (0001533615) (Filer)

Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that Henry Cole has notified the Board of Directors (the "Board") that he plans to step down as a member of the Board at the end of his current term. Henry Cole's Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company's inception and has served at different points throughout his term as the Board's Lead Independent Director, Chair of the Board's Compensation Committee and ESG Committee and as a member of the Board's Audit and Nominating and Corporate Governance Committees. Mr. Cole will be stepping down effective at the end of his current term, wh

LITTLE ROCK, Ark. and TORONTO, Jan. 2, 2026 /CNW/ - BSR Real Estate Investment Trust ("BSR" or the "REIT") (TSX:HOM) and (TSX:HOM) has announced that W. Daniel Hughes, Jr. has retired from the REIT's board of trustees (the "Board") and, in connection with the retirement, Mark Decker, Jr. has been appointed to the Board, effective January 1, 2026. W. Daniel Hughes, Jr.'s Retirement from the Board of Trustees After nearly 29 years of service with BSR and its predecessors W. Daniel Hughes, Jr. retired from the Board of the REIT effective January 1, 2026. Mr. Hughes founded Summit Housing Partners, LLC, the predecessor to BSR Trust, LLC, and served as the first Chief Executive Officer of BSR T

4 - Global Medical REIT Inc. (0001533615) (Issuer)

8-K - Global Medical REIT Inc. (0001533615) (Filer)

Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that Ronald Marston has notified the Board of Directors (the "Board") that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at different points throughout his tenure has served as the chair of the Board's Nominating and Corporate Governance Committee as well as a member of the Board's Audit and Compensation Committees. Mr. Marston's retirement will be effective

CERT - Global Medical REIT Inc. (0001533615) (Filer)

8-A12B - Global Medical REIT Inc. (0001533615) (Filer)

8-K - Global Medical REIT Inc. (0001533615) (Filer)

4 - Global Medical REIT Inc. (0001533615) (Issuer)

4 - Global Medical REIT Inc. (0001533615) (Issuer)

424B5 - Global Medical REIT Inc. (0001533615) (Filer)

SCHEDULE 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

FWP - Global Medical REIT Inc. (0001533615) (Subject)

Global Medical REIT Inc. (NYSE:GMRE) (the "Company") today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share ("Series B Preferred Stock"). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on November 20, 2025, subject to customary closing conditions. The Company expects to receive gross proceeds of approximately $50,000,000, before deducting underwriting discounts and commissions and estimated offering expenses. The Company has granted the underwriters a 30-day option to purchase up to an additional 300,0

424B5 - Global Medical REIT Inc. (0001533615) (Filer)

8-K - Global Medical REIT Inc. (0001533615) (Filer)

Global Medical REIT Inc. (NYSE:GMRE) (the "Company") today announced the commencement of an underwritten public offering of shares of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share ("Series B Preferred Stock"), subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional shares of Series B Preferred Stock to cover over-allotments, if any. The Company intends to use the net proceeds from the offering for general corporate purposes, which may include funding new acquisitions and repaying indebtedness, including amounts outstanding under the Company's credit facility. The Company intends to apply

10-Q - Global Medical REIT Inc. (0001533615) (Filer)